Mural Oncology plc
MURA
$2.08
-$0.01-0.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.01% | -7.18% | 42.43% | 38.07% | 37.08% |
| Total Depreciation and Amortization | 26.81% | 0.59% | 41.60% | 15.40% | 39.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 473.37% | -81.04% | -93.14% | -85.32% | -137.54% |
| Change in Net Operating Assets | 345.75% | 47.93% | -38.82% | 111.65% | 133.99% |
| Cash from Operations | -6.83% | 1.45% | 25.64% | 40.41% | 35.21% |
| Capital Expenditure | -- | 81.82% | 98.05% | 98.80% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -97.71% | 122.49% | -- | -- | -- |
| Cash from Investing | -95.94% | 122.47% | 3,174.19% | 1,756.35% | 6,252.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -100.00% | -99.62% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -306.56% | 94.58% | -98.36% | -- | -- |